PathMaker Neurosystems Announces Completion of Pivotal European Clinical Trial Evaluating MyoRegulator® for the Non-Invasive Treatment of Post-Stroke Spasticity
September 27, 2021 05:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, Sept. 27, 2021 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc., (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
vTv Therapeutics Announces Results of Multiple Ascending Dose Study and Development Plan for HPP737, an Oral PDE4 Inhibitor for the Treatment of Psoriasis
September 23, 2021 16:30 ET
|
vTv Therapeutics Inc.
HPP737 exhibited favorable safety and tolerability profile, with no dose limiting gastrointestinal side effects Results build on data from previous multiple ascending dose study and support...
Global $11.5 Bn Virtual Clinical Trials Markets to 2028: Need for Patient Diversity Clubbed with Enhanced Data Collection is Boosting Growth
September 21, 2021 06:58 ET
|
Research and Markets
Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "Global Virtual Clinical Trials Market Size, Share & Trends Analysis Report 2021-2028" report has been added to ResearchAndMarkets.com's offering....
Global $35 Billion Clinical Trials Support Services Markets to 2028 - Increasing Number Of CROs Providing Services
September 21, 2021 06:13 ET
|
Research and Markets
Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "Global Clinical Trials Support Services Market Size, Share & Trends Analysis Report by Phase, by Service (IRB, Clinical Trial Site Management,...
Ivy Brain Tumor Center and SonALAsense Announce Positive Initial Results of the First-in-Human Phase 0/1 Clinical Trial of Non-Invasive Sonodynamic Therapy for Recurrent Glioblastoma
September 20, 2021 12:00 ET
|
Ivy Brain Tumor Center
PHOENIX, Ariz., Sept. 20, 2021 (GLOBE NEWSWIRE) -- The Ivy Brain Tumor Center at Barrow Neurological Institute, the largest early-phase drug development program for brain cancer in the world, and...
Global Peptide Drug Conjugate Market & Clinical Trials Insights 2021-2026: Pepaxto Clinical & Commercial Insight - Dosage, Patent, Price, Sales Forecast
September 17, 2021 04:03 ET
|
Research and Markets
Dublin, Sept. 17, 2021 (GLOBE NEWSWIRE) -- The "Global Peptide Drug Conjugate Market & Clinical Trials Insight 2026" report has been added to ResearchAndMarkets.com's offering. "Global...
Perspectum Announces Partnership with Datavant to Improve Clinical Trial Recruitment with Connected Data
September 16, 2021 07:00 ET
|
Datavant
SAN FRANCISCO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Perspectum, a global quantitative and genomics-based imaging company, is joining forces with Datavant, the leader in helping healthcare...
Owkin Enters Into Agreement to Build Innovative Methods With the Potential to Enhance AI-Enabled External Control Arms
September 15, 2021 09:00 ET
|
Owkin
NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Owkin, a startup pioneering Federated Learning and AI technologies for medical research and clinical development, announces an agreement with Actelion...
Syneos Health Acquires StudyKIK
September 14, 2021 17:30 ET
|
Syneos Health, Inc.
MORRISVILLE, N.C., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of StudyKIK, a...
UPDATE -- Axiom Presents "Rare Disease Studies – Using technology to expand the opportunities of enrollment" at Clinical Trials in Rare Diseases Conference 2021
September 14, 2021 10:20 ET
|
Axiom Real-Time Metrics Inc
TORONTO, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations,...